Oxidative alterations and hyperlipidemia in diabetes facilitate ox-LDL formation, which, together with inhibition of the release of endothelium-derived relaxation factor (EDRF), finally leads to endothelial dysfunction, inflammation, and vascular injury [9, 54]. This evidence concerns the gene AHSP and endothelial dysfunction.